Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 17, 2015 (11 years ago)

labetalol HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

labetalol HCl, 5 mg per mL, 20 mg per 4 mL, 4 mL total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3117.

Drug: Labetalol

Recalling firm
Pharmedium Services, LLC
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0058-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Labetalol recalls

See all
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross contamination due to product carry over.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-0064-2023
Class II · Moderate risk

PF-Labetalol HCl Injection

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Terminated Cross-contamination Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-1347-2022

Other recalls by Pharmedium Services, LLC

All 2015 recalls